Cargando…
Copper-64: a real theranostic agent
Ongoing studies of physiological and pathological processes have led to a corresponding need for new radiopharmaceuticals, especially when studies are limited by the absence of a particular radiolabeled target. Thus, the development of new radioactive tracers is highly relevant and can represent a s...
Autores principales: | Gutfilen, Bianca, Souza, Sergio AL, Valentini, Gianluca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173185/ https://www.ncbi.nlm.nih.gov/pubmed/30323557 http://dx.doi.org/10.2147/DDDT.S170879 |
Ejemplares similares
-
Copper-64 Dichloride as Theranostic Agent for Glioblastoma Multiforme: A Preclinical Study
por: Ferrari, Cristina, et al.
Publicado: (2015) -
Chelation of Theranostic Copper Radioisotopes with S-Rich Macrocycles: From Radiolabelling of Copper-64 to In Vivo Investigation
por: Tosato, Marianna, et al.
Publicado: (2022) -
Radiopharmaceuticals in Nuclear Medicine: Recent Developments for SPECT and PET Studies
por: Gutfilen, Bianca, et al.
Publicado: (2014) -
Biokinetic and dosimetric aspects of (64)CuCl(2) in human prostate cancer: possible theranostic implications
por: Righi, Sergio, et al.
Publicado: (2018) -
In vitro and in vivo characterization of [(64)Cu][Cu(elesclomol)] as a novel theranostic agent for hypoxic solid tumors
por: Liu, Tengzhi, et al.
Publicado: (2023)